Skip to main content
TipRanks
Go Ultimate75% OFF

Mega Genomics Limited (6667) Financial Statements

0 Followers

Mega Genomics Limited Financial Overview

Mega Genomics Limited's market cap is currently ¥1.50B. The company's EPS TTM is ¥0.12; its P/E ratio is 47.78; and it has a dividend yield of 2.54%. Mega Genomics Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 164.23M¥ 247.15M¥ 151.30M¥ 145.73M¥ 237.19M
Gross Profit¥ 119.35M¥ 117.36M¥ 88.30M¥ 81.72M¥ 166.68M
Operating Income¥ 41.39M¥ 39.13M¥ 18.53M¥ -41.36M¥ 103.16M
EBITDA¥ 70.03M¥ 49.68M¥ 52.42M¥ -5.42M¥ 116.67M
Net Income¥ 45.05M¥ 27.02M¥ 30.04M¥ -17.62M¥ 79.02M
Balance Sheet
Cash & Short-Term Investments¥ 490.26M¥ 435.70M¥ 518.29M¥ 399.83M¥ 239.10M
Total Assets¥ 738.48M¥ 832.40M¥ 796.54M¥ 705.70M¥ 772.18M
Total Debt¥ 34.40M¥ 29.37M¥ 48.56M¥ 10.99M¥ 11.57M
Net Debt¥ -455.86M¥ -386.22M¥ -469.73M¥ -388.85M¥ -227.53M
Total Liabilities¥ 123.80M¥ 221.46M¥ 151.72M¥ 87.70M¥ 77.69M
Stockholders' Equity¥ 614.68M¥ 610.94M¥ 644.83M¥ 618.00M¥ 694.50M
Cash Flow
Free Cash Flow¥ 56.38M¥ -16.68M¥ 127.59M¥ -12.10M¥ 26.21M
Operating Cash Flow¥ 57.15M¥ -16.52M¥ 163.68M¥ -6.91M¥ 30.63M
Investing Cash Flow¥ 6.63M¥ -16.88M¥ -33.75M¥ -2.56M¥ -1.71M
Financing Cash Flow¥ -91.85M¥ -41.27M¥ -12.91M¥ 158.46M¥ 2.62M

Currency in CNY

Mega Genomics Limited Earnings and Revenue History

-150M0150M300M-25 %0 %25 %50 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

Mega Genomics Limited Liabilities to Assets

0300M600M900M0 %50 %100 %150 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Mega Genomics Limited Cash Flow

-150M-100M-50M050M100M150M200M20182019202020212022202320242025OperatingInvestingFinancing

Mega Genomics Limited Forecast EPS vs Actual EPS

000.10.10.20.20.3Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss